 |
Intelpharm 603000 Nizhny Novgorod, Kostina St.- 4, room 500 Phone: +7 (831) 430-02-06 Fax: +7 (831) 433-00-03 |
Health is
an absolute value We protect people's health,
the health of our society and our civilization. We create and protect
absolute values. |
|
Search
|
||||||
|
|
|
Main > Articles > Bioprost > The study was held on the basis of FGU Urology Research and Development Institute of Roszdrav. The main performers: deputy director of FGU Urology Research and Development Institute of Roszdrav, Professor S.P. Darenkov; a research assistant of the reconstructive uronephrology department FGU Urology Research and Development Institute of Roszdrav , Doctor of Medicine, Yu. V. Samsonov. The goal of the present trial is to study the efficacy and safety of Bioprost®, manufactured by ZAO Intelpharm®, in the treatment of benign prostatic hyperplasia, to determine the therapeutic activity, possibility and efficacy of the clinical application of the medicine. Modern schemes of the treatment of different forms of chronic prostatitis attach a great importance to vegetable drugs which possess efficiency, safety and a possibility of durable use as their distinctive features. Chronic bacterial and non-bacterial prostatitis has gained currency both among young and elderly men. About 40 % of men under 35 suffer from this illness that is why the appearance of Bioprost® on the pharmaceutical market is very timely. |
|
|
About us Contacts News Our Products
Copyright © Intelpharm 1997 - 2024 |
Developed by Web Ìåõàíèêà |
|